Cardiogen

People reach for Cardiogen for heart support as they get older. It's sold as the heart and blood vessel member of the Khavinson bioregulator family, and the people buying it are mostly building a healthy-aging routine rather than treating anything in particular. The searches around it ask what it's for, how much to take, and whether it does anything for blood pressure.

That interest makes sense for women in midlife. Heart disease is the leading cause of death for women in the US, and the risk climbs after menopause, when estrogen's protective effect on blood vessels fades. So a woman who's already thinking about her heart, maybe after a cholesterol result or a parent's diagnosis, is exactly who ends up reading about Cardiogen. What she finds is a compound with an interesting idea behind it and a small research file, and it helps to know which is which before spending money on it. Our answer on peptides for heart health sets it beside SS-31 and Vesugen.

Many buyers use it alongside other Khavinson peptides, matched organ by organ: pinealon for the brain, Cartalax for connective tissue, Testagen for the reproductive glands, and Cardiogen for the heart. What people report back is mixed, and it's reported experience rather than results. Some describe feeling more energetic over a course, and many describe nothing they could point to, which is what you'd expect from something meant to work slowly on tissue you can't feel.

Cardiogen comes from Vladimir Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology. The whole family rests on one idea: a peptide two to four amino acids long is small enough to get inside a cell and reach its DNA, where it helps switch the right genes back on in tissue that's slowing down with age.

Think of the heart as a busy kitchen staffed by two kinds of workers. Heart muscle cells do the actual pumping, and fibroblasts are the cleanup crew that patch damage with scar tissue. With age, or after an injury, the cleanup crew gets the upper hand and the heart stiffens. In lab dishes, the Russian group reported that Cardiogen encouraged heart muscle cells to grow while holding back fibroblast growth, and lowered a marker cells use to signal they're about to self-destruct. If that held up in people, it would mean a heart that keeps more of its pumping muscle as it ages, which is exactly why the idea is appealing and exactly why it needs testing.

The animal work points the same way. In rodent studies where a heart injury was induced on purpose, the same group reported smaller areas of damaged tissue and fewer deaths in the animals given Cardiogen. Those are the findings the whole product story leans on, and they come from one research group, in lab dishes and rodents. No human trial of Cardiogen has been published, and independent labs haven't repeated the work.

Cardiogen is usually sold as a 20 mg vial of freeze-dried powder. It's mixed with bacteriostatic water and injected under the skin. Bacteriostatic water is sterile water with a preservative, so the vial can be drawn from more than once. Like the rest of the family, it's taken in short courses with long breaks, not every day of the year.

The vial size changes the mixing math but not the daily amount, so the units to draw are worked out for the 20 mg vial on the dosage page and the reconstitution calculator handles anything else.

Two amounts are in circulation. Peptide protocol pages give 200 mcg once a day for 10 days, and peptide reference sites give about 1 mg once a day for 10 to 20 days as the community-reported range. Neither comes from a human dose-finding study. The Cardiogen dosage page lays out both with their sources, plus the units to draw and how long a vial lasts.

The course pattern is steadier than the amount. Protocol pages describe two to three courses a year with several months between them, which is the Russian bioregulator convention. Once water goes into a vial it keeps for 28 days in the fridge, so a vial mixed for a 200 mcg course will mostly go unused before the next course comes around.

Nobody has published a human safety study on Cardiogen, so there's a lot of blank space here. What people report is mostly mild redness or itching where they injected, and sometimes a headache. Serious reactions aren't described in the reports we found, and a short list of reports isn't the same as a clean record.

People who get irritation at the spot usually move to a fresh spot each day, and people who get a headache that won't clear usually stop the course. If you notice anything heart-related during a course, a racing or skipping heartbeat, chest discomfort or unusual breathlessness, that isn't a side effect to wait out. Get checked the same day.

Because Cardiogen is sold for the heart, the people most interested in it are often the ones who already take something for their heart. Blood pressure medication, blood thinners, statins and heart rhythm drugs have never been tested alongside it, and it isn't a stand-in for any of them. There's no data on pregnancy or breastfeeding. For a compound this thinly studied, purity matters more than usual, so look for a vendor that posts a recent third-party certificate of analysis, the lab report showing what's actually in the vial and how pure it is.

You'll also see heart bioregulator capsules sold as supplements. Some contain a synthetic peptide and some contain a tissue extract, and the amount per capsule is set for swallowing, not injecting. The doses don't carry over between the two, so the amounts on our dosage page apply only to the vial.

Cardiogen isn't approved by the FDA, and it isn't a prescription drug anywhere. In the US it's sold as a research compound, which is legal to buy and sell under that label. In Russia, companies sell Khavinson-family peptides as dietary supplements rather than as medicines.

The research label means quality varies by vendor and nobody checks it for you before it ships. That's the gap our vendor checks are built for. We look at independent lab testing, posted certificates of analysis, vendor history and community reputation, and every vendor is held to the same standard whether or not it pays us anything. Compare the price per milligram, not the price per vial, since a 20 mg vial at one store and a 10 mg vial at another aren't the same buy.

We haven't written a This vs. That page for Cardiogen yet. It's usually weighed against the rest of the Khavinson family. Epithalon is the best-known member and has the most research behind it, pinealon is the brain-focused one, and Vilon is the two-amino-acid immune one. For heart and blood vessel support from a different angle, SS-31 is the peptide studied for the energy-making machinery inside heart cells.

It's sold for research, and the big human trials haven't been run yet. You knew that, it's why you're reading this and not the label.